Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/KS/Topeka
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Topeka, KS

Studies commonly pay $75 to $4,500 per completed study

109 clinical trials are currently recruiting participants within 30 miles of Topeka. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

109studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Topeka right now

Top 25 of 109 recruiting studies, sorted by proximity — each links to its official registry page

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
Cotton O'Neil Cancer Center / Stormont Vail Health — Topeka, Kansas (1.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05564390)

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8 Phase 3 Interventional 474 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05624996)

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Multiple conditions Phase 3 Interventional 158 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06589804)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Lawrence Memorial Hospital — Lawrence, Kansas (25.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8 Phase 3 Interventional 486 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT07097142)

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Phase 3 Interventional 466 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT07321652)

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Atherosclerotic Cardiovascular Disease, Overweight Phase 3 Interventional 12,800 participants sought
Cotton-ONeil Diabetes and Endocrinology Center — Topeka, Kansas (1.3 mi) · Sponsor: Amgen
See eligibility & contact on ClinicalTrials.gov (NCT07037433)

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

Mantle Cell Lymphoma Phase 3 Interventional 421 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05976763)

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

Crohn Disease Phase 2 Interventional 60 participants sought
Cotton O'Neil Digestive Health Center — Topeka, Kansas (1.3 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07483099)

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

Locally Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8 Phase 1, Phase 2 Interventional 92 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04172532)

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Crohn Disease Phase 3 Interventional 530 participants sought
Cotton-O'Neil Clinical Research Center — Topeka, Kansas (1.3 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07499232)

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Colitis, Ulcerative Phase 3 Interventional 882 participants sought
Cotton O'Neil Digestive Health Center — Topeka, Kansas (1.3 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07196748)

A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)

Pneumococcal Infection Phase 1 Interventional 210 participants sought
Cotton O'Neil Research Center ( Site 1039) — Topeka, Kansas (1.3 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT07300267)

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8 Phase 3 Interventional 1,209 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05946213)

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Lung Non-Small Cell Carcinoma Phase 2 Interventional 88 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT06116682)

Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery

Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7, Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7 Phase 2 Interventional 82 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT03493425)

A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain

Osteoarthritis, Knee, Diabetic Neuropathic Pain Phase 2 Interventional 10,000 participants sought
Cotton O'Neil Clinical Research Center - Central Office — Topeka, Kansas (1.3 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT05986292)

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 1,100 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06632327)

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma Phase 3 Interventional 1,260 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06931340)

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

Non Small Cell Lung Cancer Phase 3 Interventional 630 participants sought
Cotton O'Neil Clinical Research Center - 1151 — Topeka, Kansas (1.3 mi) · Sponsor: OncoC4, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05671510)

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma Phase 2, Phase 3 Interventional 224 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06203600)

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 1,524 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06876714)

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 247 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04269902)

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

Hypothyroidism Phase 2, Phase 3 Interventional 2,800 participants sought
Cotton O'Neil Diabetes & Endocrinology /ID# 256749 — Topeka, Kansas (1.3 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06345339)
Actively enrolling

Studies you may be able to join near Topeka

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Topeka

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Cotton O’Neil Clinical Research Center

★ 5.0
and Basement, 823 SW Mulvane St 2nd Floor, Topeka, KS 66606
(785) 354-6000

KMC Research Center

★ 5.0
2200 SW 6th Ave, Topeka, KS 66606
(785) 295-0938
"Alyssa Nash was soooo supportive when answering my questions about a trial I’m thinking about taking part in. She made me feel so much more confident…"
— Natalie Bowman, 5★

Kansas Health Institute

★ 4.4
212 SW 8th Ave #300, Topeka, KS 66603
(785) 233-5443
"Health issues look at for my son"
— raymond foster, 4★

Stormont Vail Hospital - Topeka Campus

★ 2.6
1500 SW 10th Ave, Topeka, KS 66604
(785) 354-6000

Stormont Vail Health Cancer Center

★ 4.0
1414 SW 8th Ave, Topeka, KS 66606
(785) 354-5300
"Told me they didn't feel like doing further testing because it was "too expensive" still sick, still no answers, I wouldn't be surprised if this clin…"
— Malachite Hughes, 1★

Kansas Medical Clinic PA

★ 3.5
2200 SW 6th Ave, Topeka, KS 66606
"The Doctors and nurses were wonderful. The billing department is worthless. Heave BC BS of North Carolina. They it to Ks and refused to reprocess. H…"
— Trish Parre, 5★

Stormont Vail Health

★ 3.0
929 SW Mulvane St Fl 1, Topeka, KS 66606
(785) 354-6000
"Amanda at the front desk was very nice and helpful. Y’all are lucky to have her."
— Andy Smith, 5★

University of Kansas Medical Center Research Institute

★ 5.0
3901 Rainbow Blvd, Kansas City, KS 66160
(913) 588-1261
"The doctors are very nice and helpful."
— Everian Williams, 5★

Clinical Research Consultants

★ 4.6
3930 Washington St, Kansas City, MO 64111
(816) 756-1222
"They are the best especially my girl chandrika.she comes with great medical knowledge.i recommend everyone to Check them out."
— Edna Yancy, 5★

Clinical trials in Topeka: what's recruiting

The Topeka area currently has 109 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Topeka, the most active research areas are:

  • Cancer & Oncology18 studies
  • Immune & Skin4 studies
  • Diabetes & Metabolism2 studies
  • Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Topeka, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Topeka

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Topeka participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Topeka pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Topeka safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
What is the difference between a research center and a hospital study in Topeka?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Topeka?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Topeka.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Topeka typically complete one or two studies per year.

Paid clinical trials near Topeka

Other metros within reach

Olathe, KS1,030 Kansas City, KS1,035 Overland Park, KS1,023 Kansas City, MO1,024 Lincoln, NE162 Wichita, KS154 Omaha, NE595 Tulsa, OK173

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Topeka Bladder Issues Due To Spinal Cord Injury in Topeka All conditions

More of KS

Kansas City1,035 Olathe1,030 Overland Park1,023 Wichita154

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts